A new predictor for type 2 diabetes?

Sorisky, Alexander
January 2008
CMAJ: Canadian Medical Association Journal;1/29/2008, Vol. 178 Issue 3, p313
Academic Journal
The article reports on the research revealing the rising incidence of type 2 diabetes due to the increasing prevalence of obesity and the dysfunctional state of the adipose tissue associated with obesity. Researchers informs that adipose tissue actively manages complex energy exchanges and produces a variety of influential bioactive factors, which dysfunction is induced by obesity. Research results assessed that breast size at the age of 20 is a meaningful predictor of the development of type 2 diabetes. However, it suggests to further research regarding the determination of a person who is predisposed to diabetes to design more interventions for diabetes prevention.


Related Articles

  • Exposure to fine airborne particulate matter induces macrophage infiltration, unfolded protein response, and lipid deposition in white adipose tissue. Mendez, Roberto; Ze Zheng; Zhongjie Fan; Rajagopalan, Sanjay; Qinghua Sun; Kezhong Zhang // American Journal of Translational Research;2013, Vol. 5 Issue 2, p224 

    Recent epidemiological studies have suggested a link between exposure to ambient air-pollution and susceptibility to metabolic disorders such as Type II diabetes mellitus. Previously, we provided evidence that both short-and long-term exposure to concentrated ambient particulate matter with...

  • Metabolic disorders: Finding the T in fat. Bird, Lucy // Nature Reviews Drug Discovery;Sep2009, Vol. 8 Issue 9, p699 

    The article provides information on the research by three independent groups which reveal the association between T cells and metabolic disorders linked with obesity. It states that obesity is often associated with chronic inflammation in adipose tissue with macrophages that enlarge with the...

  • The Fat Controller: Adipocyte Development Stephens, Jacqueline M. // PLoS Biology;Nov2012, Vol. 10 Issue 11, p1 

    Obesity is a condition characterized by excess adipose tissue that results from positive energy balance and is the most common metabolic disorder in the industrialized world. The obesity epidemic shows no sign of slowing, and it is increasingly a global problem. Serious clinical problems...

  • Human subcutaneous adipose tissue Glut 4 mRNA expression in obesity and type 2 diabetes. Kouidhi, Soumaya; Berrhouma, Rym; Rouissi, Kamel; Jarboui, Slim; Clerget-Froidevaux, Marie-Stéphanie; Seugnet, Isabelle; Bchir, Fattouma; Demeneix, Barbara; Guissouma, Hajer; Elgaaied, Amel // Acta Diabetologica;Apr2013, Vol. 50 Issue 2, p227 

    Cellular resistance to insulin caused by reduced glucose transport and metabolism is a primary defect leading to the development of metabolic disease. While the etiology of insulin resistance is multifactorial, reduced insulin action is associated with impaired activity of the glucose...

  • Fighting Fat With Fat: Brown Adipose Tissue. Panda, Suchismita; Mangaraj, Manaswini // International Journal of Biological & Medical Research;2014, Vol. 5 Issue 3, p4382 

    Obesity is the most common metabolic disorder that has become a global problem. The serious clinical problems associated with obesity include an increased risk for type 2 diabetes mellitus, atherosclerosis and cancer. Understanding the origin and development of adipocyte and excess adipose...

  • Increased In Vivo Regeneration of Cortisol in Adipose Tissue in Human Obesity and Effects of the 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor Carbenoxolone. Sandeep, Thekkepat C.; Andrew, Ruth; Homer, Natalie Z. M.; Andrews, Robert C.; Smith, Ken; Walker, Brian R. // Diabetes;Mar2005, Vol. 54 Issue 3, p872 

    11β-Hydroxysteroid dehydrogenase type 1 (11HSD1) regenerates cortisol from cortisone within adipose tissue and liver. 11HSD1 inhibitors may enhance insulin sensitivity in type 2 diabetes and be most efficacious in obesity when 11HSD1 is increased in subcutaneous adipose biopsies. We examined...

  • Impaired Local Production of Proresolving Lipid Mediators in Obesity and 17-HDHA as a Potential Treatment for Obesity-Associated Inflammation. Neuhofer, Angelika; Zeyda, Maximilian; Mascher, Daniel; Itariu, Bianca K.; Murano, Incoronata; Leitner, Lukas; Hochbrugger, Eva E.; Fraisl, Peter; Cinti, Saverio; Serhan, Charles N.; Stulnig, Thomas M. // Diabetes;Jun2013, Vol. 62 Issue 6, p1945 

    Obesity-induced chronic low-grade inflammation originates from adipose tissue and is crucial for obesity-driven metabolic deterioration, including insulin resistance and type 2 diabetes. Chronic inflammation may be a consequence of a failure to actively resolve inflammation and could result from...

  • Disruption of Hypoxia-Inducible Factor 1 in Adipocytes Improves Insulin Sensitivity and Decreases Adiposity in High-Fat Diet-Fed Mice. Jiang, Changtao; Qu, Aijuan; Matsubara, Tsutomu; Chanturiya, Tatyana; Jou, William; Gavrilova, Oksana; Shah, Yatrik M.; Gonzalez, Frank J. // Diabetes;Oct2011, Vol. 60 Issue 10, p2484 

    OBJECTIVE-Obesity, insulin resistance, and type 2 diabetes form a tightly correlated cluster of metabolic disorders in which adipose is one of the rst affected tissues. The role of hypoxia and hypoxia-inducible factor 1 (HIF1) in the development of high-fat diet (HFD)-induced obesity and insulin...

  • Contribution of CB1 blockade to the management of high-risk abdominal obesity. Després, J-P; Lemieux, I; Alméras, N; Després, J-P; Alméras, N // International Journal of Obesity;Apr2006 Supplement 1, Vol. 30, pS44 

    The worldwide increase in the prevalence of type 2 diabetes represents a tremendous challenge for our healthcare system, especially if we consider that this phenomenon is largely explained by the epidemic of obesity. However, despite the well-recognized increased morbidity and mortality...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics